Abstract
Recent data on Duchenne muscular dystrophy (DMD) show myocyte progenitor’s involvement in the disease pathology often leading to the DMD patient’s death. The molecular mechanism underlying stem cell impairment in DMD has not been described. We created dystrophin-deficient human pluripotent stem cell (hPSC) lines by reprogramming cells from two DMD patients, and also by introducing dystrophin mutation into human embryonic stem cells via CRISPR/Cas9. While dystrophin is expressed in healthy hPSC, its deficiency in DMD hPSC lines induces the release of reactive oxygen species (ROS) through dysregulated activity of all three isoforms of nitric oxide synthase (further abrev. as, NOS). NOS-induced ROS release leads to DNA damage and genomic instability in DMD hPSC. We were able to reduce both the ROS release as well as DNA damage to the level of wild-type hPSC by inhibiting NOS activity.
Funder
Campus France
Seventh Framework Programme
Association Française contre les Myopathies
Fondation pour la Recherche Médicale
European Society of Cardiology
Reference98 articles.
1. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
2. The muscular dystrophies
3. Apoptosis precedes necrosis of dystrophin-deficient muscle;Tidball;J. Cell Sci.,1995
4. Ultrastructural and morphometrical analysis of apoptosis stages in cardiomyocytes of MDX mice;Mikhaĭlov;Tsitologiia,2001
5. The Heart in Human Dystrophinopathies
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献